O6.02 ANALYSIS OF PD1 AND PD-L1 EXPRESSION IN GLIOBLASTOMA

BACKGROUND: Immune checkpoint inhibitors targeting programmed cell death (PD)1 and PD-ligand (L)1 show promising clinical activity in various solid extracranial cancers. Expression of PD1 on tumor infiltrating T lymphocytes and PD-L1 expression on tumor cells were postulated to have predictive value...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Berghoff, A.S., Kiesel, B., Widhalm, G., Wöhrer, A., Dieckmann, K., Filipits, M., Marosi, C., Hainfellner, J.A., Preusser, M., Wick, W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Oral Presentations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185805/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.43
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak